Wells Fargo is Health Catalyst, Inc. I collect PT using (HCAT). Maintain a “purchase” rating
Health Catalyst, Inc. (NASDAQ:hcat), stock prices below $10, strong hedge fund interest, and low-price return rates are According to hedge funds, the most undervalued cloud stock below $10.
Datacenter operators working in server racks highlight the company’s cloud services.
On July 1, 2025, Wells Fargo was released on Health Catalyst, Inc. (NASDAQ: HCAT) price target was set at $10 and maintains the “buy” rating. HCAT’s stock is currently trading at around $4, meaning an important advantage, according to analysts.
Analysts include Health Catalyst, Inc. (NASDAQ: HCAT) is rated far lower than its peers, and believes it is achieving future growth through consistent performance. The company expects its bookings to grow aggressively in the next second quarter.
Meanwhile, the company’s strong revenue visibility for 2025 has been attracting attention along with the expected acceleration in DOS client growth. Going forward, analysts hope that the company will improve its dollar-based retention rate and strengthen its customer loyalty and revenue base. On the other hand, legislative uncertainty is expected to be a short-term concern with minimal long-term impact. Finally, the company’s EBITDA growth was also highlighted as an important reason for its optimistic outlook.
Health Catalyst Ignite, Health Catalyst, Inc, a cloud-based data and analytics platform. (NASDAQ: HCAT) strengthens clinical, financial and operational outcomes and serves healthcare entities. Included in our list of the best cloud stocks.
Although we acknowledge the potential of HCAT as an investment, we believe certain AI stocks offer greater promotion potential and pose a risk of decline. If you’re looking for a highly undervalued AI stock that can make a significant profit from the tariff and supervision trends of the Trump era, check out our free report. Best Short-Term AI Stocks.
Read next: Analysts say they buy 14 cheap modes of transportation and The best mineral stocks to buy according to hedge funds.
Disclosure: None.